Cargando…
Correlation Between Genetic Abnormalities in Induced Pluripotent Stem Cell-Derivatives and Abnormal Tissue Formation in Tumorigenicity Tests
Cell therapy using induced pluripotent stem cell (iPSC) derivatives may result in abnormal tissue generation because the cells undergo numerous cycles of mitosis before clinical application, potentially increasing the accumulation of genetic abnormalities. Therefore, genetic tests may predict abnorm...
Autores principales: | Yamamoto, Takako, Sato, Yoji, Yasuda, Satoshi, Shikamura, Masayuki, Tamura, Takashi, Takenaka, Chiemi, Takasu, Naoko, Nomura, Masaki, Dohi, Hiromi, Takahashi, Masayo, Mandai, Michiko, Kanemura, Yonehiro, Nakamura, Masaya, Okano, Hideyuki, Kawamata, Shin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9154342/ https://www.ncbi.nlm.nih.gov/pubmed/35445254 http://dx.doi.org/10.1093/stcltm/szac014 |
Ejemplares similares
-
Human Genomic Safe Harbors and the Suicide Gene‐Based Safeguard System for iPSC‐Based Cell Therapy
por: Kimura, Yasuyoshi, et al.
Publicado: (2019) -
Tumorigenicity Studies of Induced Pluripotent Stem Cell (iPSC)-Derived Retinal Pigment Epithelium (RPE) for the Treatment of Age-Related Macular Degeneration
por: Kanemura, Hoshimi, et al.
Publicado: (2014) -
Synthetic mRNA‐based differentiation method enables early detection of Parkinson's phenotypes in neurons derived from Gaucher disease‐induced pluripotent stem cells
por: Akiyama, Tomohiko, et al.
Publicado: (2020) -
Deconstructing Stem Cell Tumorigenicity: A Roadmap to Safe Regenerative Medicine
por: Knoepfler, Paul S
Publicado: (2009) -
Concise Review: Patient-Specific Stem Cells to Interrogate Inherited Eye Disease
por: Giacalone, Joseph C., et al.
Publicado: (2016)